64 related articles for article (PubMed ID: 2120489)
1. [Tau protein and beta protein].
Nukina N
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):276-9. PubMed ID: 2120489
[TBL] [Abstract][Full Text] [Related]
2. [Biochemistry of alzheimer's disease].
Hasegawa N; Ihara Y
Nihon Naika Gakkai Zasshi; 1991 Jan; 80(1):119-23. PubMed ID: 1673700
[No Abstract] [Full Text] [Related]
3. Biochemical and anatomical redistribution of tau protein in Alzheimer's disease.
Mukaetova-Ladinska EB; Harrington CR; Roth M; Wischik CM
Am J Pathol; 1993 Aug; 143(2):565-78. PubMed ID: 8342603
[TBL] [Abstract][Full Text] [Related]
4. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P
Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796
[TBL] [Abstract][Full Text] [Related]
5. Tau protein immunoreactivity in dementia of the Alzheimer type: II. Electron microscopy and pathogenetic implications. Effects of fixation on the morphology of the Alzheimer's abnormal filaments.
Papasozomenos SC
Lab Invest; 1989 Mar; 60(3):375-89. PubMed ID: 2494388
[TBL] [Abstract][Full Text] [Related]
6. [Cellular lesions in Alzheimer's disease: structural and molecular analysis].
Brion JP
Bull Mem Acad R Med Belg; 1992; 147(11-12):481-9; discussion 490-1. PubMed ID: 1341572
[TBL] [Abstract][Full Text] [Related]
7. [Abnormal proteins in the brain in Alzheimer's disease].
Kanemaru K; Ihara Y
Tanpakushitsu Kakusan Koso; 1991 Jan; 36(1):2-11. PubMed ID: 1900947
[No Abstract] [Full Text] [Related]
8. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
9. Neuritic pathology and dementia in Alzheimer's disease.
McKee AC; Kosik KS; Kowall NW
Ann Neurol; 1991 Aug; 30(2):156-65. PubMed ID: 1910274
[TBL] [Abstract][Full Text] [Related]
10. Tau and ubiquitin immunoreactivity at different stages of formation of Alzheimer neurofibrillary tangles.
Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
Prog Clin Biol Res; 1989; 317():837-48. PubMed ID: 2557644
[TBL] [Abstract][Full Text] [Related]
11. Sequestration of tau by granulovacuolar degeneration in Alzheimer's disease.
Bondareff W; Wischik CM; Novak M; Roth M
Am J Pathol; 1991 Sep; 139(3):641-7. PubMed ID: 1909492
[TBL] [Abstract][Full Text] [Related]
12. [Tau, amyloid and Alzheimer's disease].
Olesen OF
Ugeskr Laeger; 1994 Feb; 156(8):1116-7, 1121-4. PubMed ID: 8116089
[TBL] [Abstract][Full Text] [Related]
13. Brain site-specific gene expression analysis in Alzheimer's disease patients.
Yokota T; Mishra M; Akatsu H; Tani Y; Miyauchi T; Yamamoto T; Kosaka K; Nagai Y; Sawada T; Heese K
Eur J Clin Invest; 2006 Nov; 36(11):820-30. PubMed ID: 17032350
[TBL] [Abstract][Full Text] [Related]
14. Increased tau accumulation in senile plaques as a hallmark in Alzheimer's disease.
Shin RW; Ogomori K; Kitamoto T; Tateishi J
Am J Pathol; 1989 Jun; 134(6):1365-71. PubMed ID: 2502927
[TBL] [Abstract][Full Text] [Related]
15. [Importance of neurofibrillary degeneration in the diagnosis of Alzheimer's disease].
Gómez-Ramos P; Jiménez A; Cebrián JL; Morán MA
Med Clin (Barc); 1993 Jun; 101(2):60-3. PubMed ID: 8510479
[TBL] [Abstract][Full Text] [Related]
16. Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's disease.
Kowall NW; Kosik KS
Ann Neurol; 1987 Nov; 22(5):639-43. PubMed ID: 3122646
[TBL] [Abstract][Full Text] [Related]
17. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
Joachim CL; Morris JH; Kosik KS; Selkoe DJ
Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
[TBL] [Abstract][Full Text] [Related]
18. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
Huang HC; Jiang ZF
J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
[TBL] [Abstract][Full Text] [Related]
19. Regions with abundant neurofibrillary pathology in human brain exhibit a selective reduction in levels of binding-competent tau and accumulation of abnormal tau-isoforms (A68 proteins).
Bramblett GT; Trojanowski JQ; Lee VM
Lab Invest; 1992 Feb; 66(2):212-22. PubMed ID: 1735956
[TBL] [Abstract][Full Text] [Related]
20. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice.
Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J
J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
